Filing Details

Accession Number:
0001104659-23-065680
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-30 07:30:09
Reporting Period:
2023-05-25
Accepted Time:
2023-05-30 07:30:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1175151 Cytosorbents Corp CTSO Surgical & Medical Instruments & Apparatus (3841) 980373793
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1409212 P. Kathleen Bloch C/O Cytosorbents Corporation
305 College Road East
Princeton NJ 08540
Interim Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-25 1,100 $2.85 44,800 No 4 P Indirect See footnote
Common Stock Acquisiton 2023-05-25 1,100 $2.84 45,900 No 4 P Indirect See footnote
Common Stock Acquisiton 2023-05-25 1,100 $2.85 47,000 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 397,347 Direct
Footnotes
  1. These shares are held by the Reporting Person's husband in a 401(k) account. The Reporting Person may be deemed the beneficial owner of such shares.
  2. Includes: (i) the following RSUs that will be settled into Common Stock upon a "Change In Control" of CytoSorbents Corporation (the "Company"), as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 8,800 RSUs granted on March 15, 2018, (b) 15,700 RSUs granted on February 24, 2017, (c) 47,000 RSUs granted on June 7, 2016 and (d) 110,000 RSUs granted on April 8, 2015;
  3. (continued from footnote 2) (ii) the following RSUs (which vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the Reporting Person's continued service as of the applicable vesting date), and will be settled into common stock of the Company upon vesting: 37,000 RSUs granted on August 10, 2022; and
  4. (continued from footnote 3) (iii) 178,847 shares of Common Stock owned by the Reporting Person.